期刊
CURRENT OPINION IN MICROBIOLOGY
卷 62, 期 -, 页码 21-27出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2021.04.006
关键词
-
类别
资金
- Vidi grant of the Netherlands Organization for Scientific Research
- European Union's Horizon 2020 research and innovation programme [847507 HDMFUN]
- 'La Caixa' foundation [100010434]
Invasive pulmonary aspergillosis (IPA) occurring in critically ill patients with viral pneumonitis has been increasingly reported in recent years, with influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) being the two most common forms. These diseases cause high mortality and the pathogenesis involves viral, fungal, and host factors.
The occurrence of invasive pulmonary aspergillosis (IPA) in critically ill patients with viral pneumonitis has increasingly been reported in recent years. Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) are the two most common forms of this fungal infection. These diseases cause high mortality in patients, most of whom were previously immunocompetent. The pathogenesis of IAPA and CAPA is still not fully understood, but involves viral, fungal and host factors. In this article, we discuss several aspects regarding IAPA and CAPA, including their possible pathogenesis, the use of immunotherapy, and future challenges.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据